MCID: SWL001
MIFTS: 37

Swallowing Disorders

Categories: Gastrointestinal diseases, Neuronal diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Swallowing Disorders

MalaCards integrated aliases for Swallowing Disorders:

Name: Swallowing Disorders 52 41
Deglutition Disorders 71

Classifications:



External Ids:

UMLS 71 C0011168

Summaries for Swallowing Disorders

NINDS: 52 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary: Swallowing Disorders, also known as deglutition disorders, is related to traumatic brain injury and cleft larynx, posterior, and has symptoms including nausea and vomiting, constipation and vomiting. The drugs Remifentanil and Acetaminophen have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, brain and tongue.

MedlinePlus: 41 If you have a swallowing disorder, you may have difficulty or pain when swallowing. Some people cannot swallow at all. Others may have trouble swallowing liquids, foods, or saliva. This makes it hard to eat. Often, it can be difficult to take in enough calories and fluids to nourish your body. Anyone can have a swallowing disorder, but it is more common in older adults. It often happens because of other conditions, including: Nervous system disorders, such as Parkinson's disease and cerebral palsy Problems with your esophagus, including GERD (gastroesophageal reflux disease) Stroke Head or spinal cord injury Cancer of the head, neck, or esophagus Medicines can help some people, while others may need surgery. Swallowing treatment with a speech-language pathologist can help. You may find it helpful to change your diet or hold your head or neck in a certain way when you eat. In very serious cases, people may need feeding tubes. NIH: National Institute on Deafness and Other Communication Disorders

Related Diseases for Swallowing Disorders

Diseases related to Swallowing Disorders via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 111)
# Related Disease Score Top Affiliating Genes
1 traumatic brain injury 11.0
2 cleft larynx, posterior 10.9
3 laryngotracheoesophageal cleft type 2 10.9
4 aspiration pneumonia 10.4
5 nutritional deficiency disease 10.3
6 parkinson disease, late-onset 10.3
7 head and neck cancer 10.3
8 stroke, ischemic 10.3
9 gastroesophageal reflux 10.2
10 cerebral palsy 10.2
11 neuromuscular disease 10.2
12 cerebrovascular disease 10.2
13 speech and communication disorders 10.1
14 papillon-lefevre syndrome 10.1
15 aphasia 10.1
16 parkinsonism 10.1
17 pneumonia 10.1
18 aplasia of lacrimal and salivary glands 10.0
19 respiratory failure 10.0
20 myopathy 10.0
21 dystonia 10.0
22 oropharynx cancer 10.0
23 speech disorder 10.0
24 lip and oral cavity cancer 10.0
25 ocular motor apraxia 9.9
26 pierre robin syndrome 9.9
27 sjogren syndrome 9.9
28 squamous cell carcinoma, head and neck 9.9
29 esophageal atresia 9.9
30 dementia 9.9
31 reading disorder 9.9
32 duodenal ulcer 9.9
33 larynx cancer 9.9
34 laryngeal benign neoplasm 9.9
35 alcohol dependence 9.8
36 apnea, obstructive sleep 9.8
37 autoimmune disease 9.8
38 machado-joseph disease 9.8
39 esophageal cancer 9.8
40 huntington disease 9.8
41 inclusion body myositis 9.8
42 lymphatic malformation 5 9.8
43 myotonic dystrophy 1 9.8
44 oculodentodigital dysplasia 9.8
45 oculopharyngeal muscular dystrophy 9.8
46 rheumatoid arthritis 9.8
47 schizophrenia 9.8
48 tracheoesophageal fistula with or without esophageal atresia 9.8
49 down syndrome 9.8
50 charge syndrome 9.8

Comorbidity relations with Swallowing Disorders via Phenotypic Disease Network (PDN): (show top 50) (show all 59)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Alzheimer Disease, Familial, 1
Bronchitis Bronchopneumonia
Cerebral Atherosclerosis Cerebral Degeneration
Cerebrovascular Disease Conjunctivitis
Decubitus Ulcer Deficiency Anemia
Dyskinesia of Esophagus Encephalopathy
Epilepsy, Focal, with Speech Disorder and with or Without Impaired Intellectual Development Esophageal Cancer
Esophageal Candidiasis Esophageal Disease
Esophagitis Facial Paralysis
Familial Atrial Fibrillation Generalized Atherosclerosis
Heart Disease Hypertension, Essential
Hypothyroidism Intermittent Claudication
Intracranial Embolism Intracranial Thrombosis
Iron Deficiency Anemia Kidney Disease
Kwashiorkor Larynx Cancer
Major Depressive Disorder Malignant Essential Hypertension
Marasmus Megaesophagus
Neurogenic Bladder Neuromuscular Disease
Nutritional Deficiency Disease Obstructive Hydrocephalus
Ocular Motor Apraxia Oral Candidiasis
Osteoporosis Paralytic Ileus
Parkinson Disease, Late-Onset Peripheral Vascular Disease
Pharyngitis Pharynx Cancer
Progressive Bulbar Palsy Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Swallowing Disorders:



Diseases related to Swallowing Disorders

Symptoms & Phenotypes for Swallowing Disorders

UMLS symptoms related to Swallowing Disorders:


nausea and vomiting; constipation; vomiting; abdominal pain; headache; diarrhea; nausea; odynophagia; pseudobulbar signs; dyspepsia; icterus; seizures; signs and symptoms, digestive; heartburn; gastrointestinal gas; digestive system symptom; flatulence, eructation, and gas pain; symptoms involving digestive system; other symptoms involving digestive system; pain in esophagus (finding); absent deglutition; swallowing problems; choking sensation; symptom as reason for upper g.i. examination; dysphagia, pharyngeal phase; dysphagia, pharyngoesophageal phase

Drugs & Therapeutics for Swallowing Disorders

Drugs for Swallowing Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 143)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Remifentanil Approved Phase 4 132875-61-7 60815
2
Acetaminophen Approved Phase 4 103-90-2 1983
3
Buspirone Approved, Investigational Phase 4 36505-84-7 2477
4
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
5
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
6 Analgesics Phase 4
7 Antipyretics Phase 4
8 Analgesics, Non-Narcotic Phase 4
9 Carboxymethylcellulose Sodium Phase 4
10 Serotonin Receptor Agonists Phase 4
11 HIV Protease Inhibitors Phase 4
12
protease inhibitors Phase 4
13 Protective Agents Phase 4
14 Cardiotonic Agents Phase 4
15 Antihypertensive Agents Phase 4
16 Angiotensin-Converting Enzyme Inhibitors Phase 4
17
Rabeprazole Approved, Investigational Phase 2, Phase 3 117976-89-3, 117976-90-6 5029
18
Cisplatin Approved Phase 3 15663-27-1 2767 5702198 441203
19
Zinc cation Approved, Experimental, Investigational Phase 3 7440-66-6, 23713-49-7 32051
20
Fluorouracil Approved Phase 3 51-21-8 3385
21
Ketorolac Approved Phase 3 74103-06-3, 66635-83-4 3826
22
Acetylcholine Approved, Investigational Phase 2, Phase 3 51-84-3 187
23
Nicergoline Approved, Investigational Phase 3 27848-84-6 34040
24
Carnosine Experimental, Investigational Phase 3 305-84-0, 107667-60-7 439224
25 Antimetabolites Phase 3
26 Immunosuppressive Agents Phase 3
27 Immunologic Factors Phase 3
28 Antirheumatic Agents Phase 3
29 Cyclooxygenase Inhibitors Phase 3
30 Anti-Inflammatory Agents, Non-Steroidal Phase 3
31 Adrenergic Agents Phase 3
32
abobotulinumtoxinA Phase 2, Phase 3
33 Botulinum Toxins, Type A Phase 2, Phase 3
34 Botulinum Toxins Phase 2, Phase 3
35 Cholinergic Agents Phase 2, Phase 3
36 Adrenergic Antagonists Phase 3
37 Adrenergic alpha-Antagonists Phase 3
38 Vasodilator Agents Phase 3
39 Nootropic Agents Phase 3
40
Menthol Approved, Experimental Phase 2 1490-04-6, 2216-51-5, 15356-60-2 1254 16666 165675
41
Prucalopride Approved Phase 2 179474-81-8 3052762
42
Modafinil Approved, Investigational Phase 2 68693-11-8 4236
43
Carboplatin Approved Phase 2 41575-94-4 10339178 38904
44
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
45
Lidocaine Approved, Vet_approved Phase 2 137-58-6 3676
46
Glycerin Approved, Investigational Phase 2 56-81-5 753
47
Capsaicin Approved Phase 2 404-86-4 1548943
48
Amifostine Approved, Investigational Phase 2 20537-88-6 2141
49
Piperine Investigational Phase 1, Phase 2 94-62-2 638024
50 Cytochrome P-450 Enzyme Inhibitors Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 413)
# Name Status NCT ID Phase Drugs
1 Does Opioid Induced Swallowing Difficulty Lead to Elevated Risk for Pulmonary Aspiration? Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
2 Effect of Pharyngeal Inhibition Induced by Repetitive Transcranial Stimulation in Post Stroke Dysphagia Completed NCT01081444 Phase 4
3 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
4 Neuromuscular Electroestimulation and Respiratory Muscle Training in the Management of Dysphagia of Subacute Stroke Patients Completed NCT02473432 Phase 4
5 Efficacy of IV vs Oral Administration of Acetaminophen for Pain Control Following Tonsillectomy With or Without Adenoidectomy Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
6 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
7 Impact of Single Dose Perioperative Steroids on Dysphagia Following Anterior Cervical Spine Surgery: A Randomized, Prospective, Double-Blind Study Recruiting NCT03711474 Phase 4 Dexamethasone;Saline
8 The Effect of Oral Buspirone Hydrochloride on Esophageal Motility, Bolus Transit and Symptoms of Dysphagia, in Patients With Poor Esophageal Motility: A Randomized, Double-blind, Placebo Controlled, Cross-over Trial With HRiM Recruiting NCT05629325 Phase 4 Buspirone Hydrochloride 10 MG;Placebo
9 Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills Terminated NCT03588806 Phase 4 Xtampza ER (oxycodone)
10 A Randomized Placebo Controlled Trial of Low Dose Angiotensin Converting Enzyme Inhibitor to Prevent Pneumonia in Older People Who Require Tube Feeding Because of Neurological Dysphagia Terminated NCT02358642 Phase 4 Angiotensin converting enzyme inhibitor (Lisinopril);Placebo
11 Impact of Early Percutaneous Tracheostomy on the Incidence of Swallowing Dysfunction in Critically Ill Patients on Mechanical Ventilation. A Randomized Clinical Trial Unknown status NCT01268423 Phase 3
12 The Comparison of Value of Brachytherapy and Endoscopic Stenting With SEMS in Palliative Treatment of Dysphagia Resulting From Adenocarcinoma of the Esophago-Gastric Junction Unknown status NCT01786278 Phase 2, Phase 3
13 A Randomised Controlled Trial of Dysphagia Therapies for Swallowing Disorders Following Stroke. Completed NCT00257764 Phase 2, Phase 3
14 The Effects of Intraoperative Local and Systemic Corticosteroid Administration on Postoperative Dysphagia After Anterior Cervical Fusion Completed NCT03311425 Phase 3 Methylprednisolone;Dexamethasone
15 A Randomized, Prospective Trial of Electrosurgical Incision Followed by Rabeprazole Versus Bougie Dilation Followed by Rabeprazole of Symptomatic Lower Esophageal (Schatzki's) Rings Completed NCT00204750 Phase 2, Phase 3
16 A Randomised Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated With Radiotherapy vs ChemoRadiotherapy. Completed NCT00193882 Phase 3 Cisplatin;5-Fluorouracil
17 Study for the Evaluation of the Impact of HEPILOR on the Possible Delay in the Development of Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy on the Breast/Thoracic Wall and Lymph Node Drainage. Completed NCT03997188 Phase 3
18 Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study Completed NCT01279837 Phase 2, Phase 3
19 A Randomized Controlled Trial of NMES vs. Traditional Dysphagia Therapy After Stroke Completed NCT01279824 Phase 2, Phase 3
20 The Effect of Intravenous Non-steroidal Anti-inflammatory Drugs and Intravenous Corticosteroids on the Likelihood of Dysphagia and Dysphonia Following Anterior Cervical Discectomy and Fusion Not yet recruiting NCT04650893 Phase 3 Intravenous Ketorolac;Intravenous Dexamethasone;Placebo
21 Efficacy and Safety of Onabotulinum Toxin A (Botox) Injections in the Upper Esophageal Sphincter for the Treatment of Pharyngo-esophageal Dysphagia Due to Cricopharyngeal Dysfunction- A Randomized Double Blinded Placebo Controlled Trial Not yet recruiting NCT04695600 Phase 2, Phase 3 Botulinum Toxin Type A Injection [Botox]
22 The Study of Efficacy on Low Dose Nicergoline in Dysphagia Patients Compares With High Dose Nicergoline. Not yet recruiting NCT05551182 Phase 3 Nicergoline
23 Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia Terminated NCT01971320 Phase 3
24 Effect of Intravenous Corticosteroid Injections on Dysphagia After Anterior Cervical Spine Surgery: a Randomized, Double-blind, Placebo-controlled Study Terminated NCT02266797 Phase 3 Dexamethasone
25 Effectiveness of Acupuncture-like Transcutaneous Nerve Stimulation (ALTENS) in Improving Dysphagia and Associated Symptoms of Chemotherapy and/or Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancers: A Pilot Study Unknown status NCT01697891 Phase 1, Phase 2
26 Phase 2 Study of rTMS on Poststroke Dysphagia Unknown status NCT02090231 Phase 2
27 Swallowing Rehabilitation of Dysphagic Tracheostomized Patients Under Mechanical Ventilation at Intensive Care Unit Unknown status NCT01496924 Phase 2
28 Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer Completed NCT02075385 Phase 2
29 Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging Completed NCT03050957 Phase 2
30 Effect of Natural Agonists of TRPV1 in the Treatment of Functional Oropharyngeal Dysphagia in Neurological Diseases and the Elderly: Piperine Completed NCT01383694 Phase 1, Phase 2 Piperine
31 Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts Completed NCT00773227 Phase 2
32 Efficacy of Functional Electrical Stimulation in Dysphagia of Nasopharyngeal Cancer Post Radiotherapy Completed NCT00815087 Phase 2
33 Effects of Age and Age-Related Diseases on Swallowing Completed NCT00038350 Phase 2
34 Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer Completed NCT01032928 Phase 2
35 Treatment of Dysphagia Using the Mendelsohn Maneuver Completed NCT00592761 Phase 1, Phase 2
36 Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study Completed NCT03244553 Phase 2 Prucalopride
37 Pilot Study of Transcranial Direct Current Stimulation for Facilitating Swallowing Improvement After an Acute Unilateral Hemispheric Infarction Completed NCT01132066 Phase 1, Phase 2
38 Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia Completed NCT01085903 Phase 2 Modafinil;Placebo
39 A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia Completed NCT00376506 Phase 2
40 Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy Completed NCT00332865 Phase 1, Phase 2
41 Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention Completed NCT00306501 Phase 2
42 A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Completed NCT00094861 Phase 2 Palifermin;Placebo;Paclitaxel;Carboplatin
43 Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer Completed NCT01262560 Phase 2 Manuka honey in liquid form;Manuka honey in lozenge form;Standard supportive care
44 Tongue Pressure Profile Training for Dysphagia Post Stroke Completed NCT01370083 Phase 2
45 Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia (OD). A Randomized Controlled Trial. Completed NCT01777672 Phase 2
46 Effectiveness of a New Neuromuscular Electrical Stimulation (NMES) Treatment Technique (VitalStim® Therapy) in the Management of Young Infants With Severe Dysphagia: a Prospective Pilot Study Completed NCT01723358 Phase 2
47 Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Completed NCT02927691 Phase 2
48 A Multi-Center, Double-Blind, Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Cells (AMDC) for the Treatment of Tongue Dysphagia Resulting From the Treatment of Head and Neck Cancer Recruiting NCT05421689 Phase 1, Phase 2
49 Impacts of an Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model to Prevent Swallowing Disorders in Patients Treated With Chemoradiotherapy for Head and Neck Cancer Not yet recruiting NCT05621889 Phase 1, Phase 2
50 A Multicenter, Randomized, Double-blind, Double-dummy, Positive Drug Parallel Controlled Phase II Clinical Trial to Evaluate Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis Not yet recruiting NCT05604261 Phase 2 Anaprazole sodium 40 mg;Anaprazole sodium 60 mg;Rabeprazole sodium 20 mg

Search NIH Clinical Center for Swallowing Disorders

Genetic Tests for Swallowing Disorders

Anatomical Context for Swallowing Disorders

Organs/tissues related to Swallowing Disorders:

MalaCards : Spinal Cord, Brain, Tongue, Subthalamic Nucleus, Lymph Node, Cortex, Tonsil

Publications for Swallowing Disorders

Articles related to Swallowing Disorders:

(show top 50) (show all 1234)
# Title Authors PMID Year
1
Comparison of SaCoVLM™ video laryngeal mask-guided intubation and i-gel combined with flexible bronchoscopy-guided intubation in airway management during general anesthesia: a non-inferiority study. 41
36138363 2022
2
A randomized controlled study of two different fixations in anterior cervical discectomy of multilevel cervical spondylotic myelopathy. 41
36069629 2022
3
Effect of Cold Fluid Compensatory Swallowing Combined with Balloon Dilation on the Treatment of Poststroke Cricopharyngeal Achalasia: A Pilot Randomized Controlled Trial. 41
36254140 2022
4
The role of pH-impedance monitoring in swallowing disorders. 62
36004789 2022
5
Healthy Volunteers Immediately Adapt to Submental Stimulation During Swallowing. 62
34590756 2022
6
Nutritional risk at hospital admission is associated with prolonged length of hospital stay in old patients with COVID-19. 62
33933295 2022
7
New Radioprotective Device that can be Used for Fluoroscopic Exam: Possibility to Contribute to Staff Exposure Protection During VFSS. 62
35169874 2022
8
The effects of tongue elevation using a weighted plastic bottle on the tongue pressure and activity of suprahyoid muscles. 62
36029125 2022
9
How the work of respiratory physiotherapists changes the tracheostomy management and decannulation in a NICU department: an Italian experience. 62
36426898 2022
10
Tri-lobed Tongue: Rare Manifestation Accompany With Pierre Robin Sequence. 62
36319614 2022
11
Swallowing-related quality of life in children with oesophageal atresia: a national cohort study. 62
36331620 2022
12
Flexible endoscopic evaluation of swallowing in children with type 1 spinal muscular atrophy. 62
36209319 2022
13
High-resolution esophageal manometry in children. 62
36265522 2022
14
Reliability and validity of the Turkish version of speech pathology-specific questionnaire for persons with multiple sclerosis (SMS-TR). 62
36308425 2022
15
Angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality. 62
36278479 2022
16
Instrumental Swallowing Assessments in the Neonatal and Pediatric Populations: A Systematic Review. 62
34719729 2022
17
Automated pharyngeal phase detection and bolus localization in videofluoroscopic swallowing study: Killing two birds with one stone? 62
35961072 2022
18
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion. 62
36083426 2022
19
Risk Factors for Feeding and Swallowing Disorders in Very Low Birth Weight Infants in Their Second Year of Life. 62
36363492 2022
20
The Sheba Medical Center Protocol for Bedside Evaluation of Swallowing Disorders Among Tracheotomized Patients. 62
34787704 2022
21
The effects of physiotherapy treatments on dysphagia in Parkinson's disease: A systematic review of randomized controlled trials. 62
35882280 2022
22
Translation, Cultural Adaptation, Reliability, and Validity Evidence of the Feeding/Swallowing Impact Survey (FS-IS) to Brazilian Portuguese. 62
34779911 2022
23
Quantitative Measurement of Swallowing Performance Using Iowa Oral Performance Instrument: A Systematic Review and Meta-Analysis. 62
36140420 2022
24
The Effect of Repetitive Transcranial Magnetic Stimulation in Synchronization with Effortful Swallowing on Post-stroke Dysphagia. 62
36087120 2022
25
Swallowing disorders after thyroidectomy: a systematic review and meta-analysis. 62
35438344 2022
26
Egy nemzetközi nyelészavarszűrési módszer hazai adaptálása. 62
36057872 2022
27
Clinical usefulness of transcutaneous laryngeal ultrasonography in otolaryngology practice during COVID-19 pandemic: a literature review. 62
36094753 2022
28
The Effects of Swallowing Disorders and Oral Malformations on Nutritional Status in Children with Cerebral Palsy. 62
36079915 2022
29
Swallowing Related Problems of Toddlers with Down Syndrome. 62
36118664 2022
30
Treatment Approaches for Swallowing Disorders in Children. 62
36043725 2022
31
Virtual Surgical Planning and Customized Subperiosteal Titanium Maxillary Implant (CSTMI) for Three Dimensional Reconstruction and Dental Implants of Maxillary Defects after Oncological Resection: Case Series. 62
35956210 2022
32
Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review. 62
36043981 2022
33
From DYMUS to DYPARK: Validation of a Screening Questionnaire for Dysphagia in Parkinson's Disease. 62
34264379 2022
34
Short and Long-Term Voice and Swallowing-Related Quality of Life in Patients Who Underwent Total Laryngectomy and Tracheoesophageal Puncture. 62
35928174 2022
35
Detection of swallowing disorders with a multiple-channel surface electromyography sensor sheet. 62
35784131 2022
36
Swallowing disorders and associated factors in older adults living in nursing homes. 62
35357579 2022
37
Diagnostic Accuracy of the Eating Assessment Tool-10 (EAT-10) in Screening Dysphagia: A Systematic Review and Meta-Analysis. 62
35849209 2022
38
Automated Chicago Classification for Esophageal Motility Disorder Diagnosis Using Machine Learning. 62
35890906 2022
39
Interaction between malnutrition and physical disability in older adults: is there a malnutrition-disability cycle? 62
35831980 2022
40
Efficacy of soft palatal augmentation prosthesis for oral functional rehabilitation in patients with dysarthria and dysphagia: a protocol for a randomised controlled trial. 62
35835521 2022
41
Translation and Validation of the Indonesian MD Anderson Dysphagia Inventory (MDADI) in Head and Neck Cancer Patients with Swallowing Disorders. 62
35846827 2022
42
Interprofessional Education Module on Post-Intensive Care Syndrome for Internal Medicine Residents. 62
35924197 2022
43
Nutritional status in patients with advanced-stage multiple sclerosis. 62
35152502 2022
44
Prevalence of dysphagia symptoms in Cretan children and adolescents with neurological disorders. 62
35722237 2022
45
Rice congee as an alternative to thickened liquids for patients with swallowing disorders. 62
35255166 2022
46
Protocols and assessment procedures in fiberoptic endoscopic evaluation of swallowing: an updated systematic review. 62
33895102 2022
47
Application of Ultrasonography in Neurogenic Dysphagia: A Systematic Review. 62
35556172 2022
48
The yield of solid swallows in high resolution esophageal manometry among patients with dysphagia and gastro-esophageal reflux symptoms. 62
35388665 2022
49
Advances in Management of Voice and Swallowing Disorders. 62
35566434 2022
50
White Paper by the European Society for Swallowing Disorders: Screening and Non-instrumental Assessment for Dysphagia in Adults. 62
33787994 2022

Variations for Swallowing Disorders

Expression for Swallowing Disorders

Search GEO for disease gene expression data for Swallowing Disorders.

Pathways for Swallowing Disorders

GO Terms for Swallowing Disorders

Sources for Swallowing Disorders

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....